Fingerprint
Dive into the research topics of 'A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically